An interventional study of Short term Pulmonary Rehabilitation and Box breathing with short term pulmonary rehabilitation in Pulmonary Disease, Chronic Obstructive (COPD), sponsored by Foundation University Islamabad. Recruiting at 1 site in Pakistan. Open to participants aged 40 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-04-08.
Sponsored by Foundation University Islamabad · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 78 studies in Pulmonary Disease, Chronic Obstructive with a site in Pakistan — 28 open to participants now, 28 under way, 1 of them phase 3. Pulmonary Disease, Chronic Obstructive · Pakistan.
Among the 78 studies in Pulmonary Disease, Chronic Obstructive with a site in Pakistan, this one is the 52nd largest by planned enrollment of the 75 interventional ones that give a count, is one of 12 that started in 2026, is one of 72 with no phase, reaches primary completion later than 17 of the 27 other live ones, and was the 68th registered.
5,529 studies on the registry are indexed under Pulmonary Disease, Chronic Obstructive; 858 are open to participants now.
Browse Pulmonary Disease, Chronic Obstructive studies →28 of the 78 studies in Pulmonary Disease, Chronic Obstructive with a site in Pakistan are open now. Recruiting first, the newest first:
Rashid Latif Medical College · Sites in Pakistan
Ages 20–65
Riphah International University · Sites in Pakistan
Ages 40–60
Foundation University Islamabad · Sites in Pakistan
Ages 40–65
Foundation University Islamabad · Sites in Pakistan
Ages 40–75
Foundation University Islamabad · Sites in Pakistan
Ages 40–70
A study can be open while its sites in Pakistan have not opened yet or have stopped. Only those recruiting at a site in Pakistan →
Of the 560 Pulmonary Disease, Chronic Obstructive studies recruiting now, 307 (55%) set no upper age limit and 82 (15%) stop at 75 or younger; 30 take children under 18; 88 take healthy volunteers.
This study: 40 Years to 65 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
78 studies; the count open now beside each. This study's row is marked.
First in 2000; this study’s year is marked. 12 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 40 is below the median of 62 across 3,847 interventional studies indexed under Pulmonary Disease, Chronic Obstructive.
Median enrollment 48 across the 75 interventional studies, 140 across the 3 observational. Of the 47 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
2 of 78 have an industry lead sponsor. The 10 most frequent:
Foundation University Islamabad is the lead sponsor of 255 studies on the registry; 142 are open to participants now.
Foundation University Islamabad has 6 studies filed under Pulmonary Disease, Chronic Obstructive — fewer than ten, so there is no comparison to draw.
3 of the studies in Pulmonary Disease, Chronic Obstructive with a site in Pakistan that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07875036Foundation University IslamabadComparative Effects of Coherent Breathing and Regular Paced Breathing on Dyspnea and Pulmonary Function in Patients With Chronic Obstructive Pulmonary Disease | 2026-12-15 |
| NCT07875049Foundation University IslamabadAdditional Effects of Flutter With Conventional Chest Physiotherapy on Peak Expiratory Flow Rate and Chest Expansion in Post CABG Patients With COPD | 2026-12-20 |
| NCT07708337Capital Development Authority (CDA)Evaluating Customized Antibiotic Duration (CDA) Strategy in Acute Exacerbations of COPD | 2026-12-31 |
Add all 3 to your calendar (.ics) → With an account.
Among the 78 studies in Pulmonary Disease, Chronic Obstructive with a site in Pakistan, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Chronic Obstructive Pulmonary Disease is progressive and irreversible respiratory condition characterized by persistent airflow limitation leading to dyspnea and reduced functional capacity.
Pulmonary rehabilitation along with different technqiues of breathing exercises reduces dyspnea and enhance functional capacity by improving ventilatory efficiency, respiratory muscle control and overall exercise tolerance in patients with COPD.
Chronic Obstructive pulmonary Disease is a progressive and irreversible respiratory condition characterized by persistent airflow limitation leading to dyspnea and reduced functional capacity.
Pulmonary Rehabilitation, a cornerstone in COPD management helps to reduce dyspnea and improve functional capacity. Although long-term PR programs yield sustained benefits, shorter-duration PR (e.g., 3-week interventions) may offer greater feasibility and higher patient adherence.
Total 40 participants will be allocated into two groups. Group A will be provided with short term Pulmonary rehabilitation along with pharmacological management and group B will be given additional Box breathing along with short term pulmonary rehabilitation The objective of this study is to determine the additional effects of Box breathing technique with short term pulmonary rehabilitation versus short term pulmonary rehabilitation alone on Dyspnea, Functional capacity and quality of life in patients with chronic obstructive pulmonary disease.
5,529 studies on the registry are indexed under Pulmonary Disease, Chronic Obstructive; 858 are open to participants now.
This study's planned enrollment of 40 is below the median of 62 across 3,847 interventional studies indexed under Pulmonary Disease, Chronic Obstructive.
Browse Pulmonary Disease, Chronic Obstructive studies →Foundation University Islamabad is the lead sponsor of 255 studies on the registry; 142 are open to participants now.
Compared within Pulmonary Disease, Chronic Obstructive, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Lung Diseases. The counts are of registry records indexed under each term, refreshed daily. How we classify →
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
From a breathing test (spirometry): how much air you can blow out in the first second. Often given as a percentage of what is expected for your age, height and sex.
COPD
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
FEV1
From a breathing test (spirometry): how much air you can blow out in the first second. Often given as a percentage of what is expected for your age, height and sex.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Patients in this group will receive Short term pulmonary rehabilitation along with pharmacological management. Two sessions per week, supervised by physiotherapist will be conducted for a total of 3 weeks.
Other: Short term Pulmonary Rehabilitation
Patients in this group will receive Box breathing as well as short term pulmonary rehabilitation along with pharmacological management. Two sessions per weeek, supervised by physiotherapist will be conducted for a total of 3 weeks. In Group B, box breathing will be performed daily. A home diary will be provided in order to ensure and follow-up that the participants are performing breathing exercise at home.
Other: Box breathing with short term pulmonary rehabilitation
Patients in this group will receive short term pulmonary rehabilitation along with pharmacological management. A total of 3 weeks protocol will be followed in which 2 seesions per week will be supervised by physiotherapist. Short term pulmonary rehabilitation includes: Warm-up(5-7min): light walking Aerobic training: mild-moderate intensity (40-60% of MHR) cycling or walk on treadmill/over ground Strength training: Exercises for major muscle groups (upper limb, lower limb and trunk) using body weight based on 1RM. Upper limb: upright row, shoulder press, bicep curls Lower limb: sit-to-stand, mini knee lifts, 3 steps calf raises Core: Seated abdominal contraction, back extension Perform 1-2 sets of 5-10 repetitions for each exercise, resting 1-2 mins between sets. Breathing exercise: pursed-lip breathing (1-3 sets of 5-10 reps) Cool down: (5-10min) Pharmacological management: Patient will receive medications as per prescribed by pulmonologist
Patients in this group will receive box breathing with short term pulmonary rehabilitation along with pharmacological management. A total 3 weeks protocol will be followed in which 2 sessions per week will be supervised by physiotherapist and box breathing will be performed daily. Patient will receive short term pulmonary rehabilitation including: Warm -up (5-7 min): light walking Aerobic training: mild-moderate intensity (40-60%of MHR) cycling or walk on treadmill/over ground. Strength training: Exercises for major muscle groups (upper limb, lower limb and trunk) using body weight based on 1RM. Upper limb: upright row, shoulder press, bicep curls Lower limb: sit-to-stand, mini knee lifts, 3 steps calf raises Core: seated abdominal contractions, back extensions Perform 1-2 sets of 5-10 repetitions for each exercise resting 1-2 min between sets. Breathing exercise: pursed-lip breathing (1-3 sets of 5 -10 repetitions) Cool down: (5-10 min) Box breathing: The patient will be instructed
Dyspnea
Evaluation will be performed using the Modified Medical Research Council (mMRC) Dyspnea Scale, a clinician-administered scale ranging from 0 to 4, where: 0 indicates breathlessness only with strenuous exercise 4 indicates severe breathlessness (too breathless to leave the house or breathless while dressing) Higher scores represent worse dyspnea severity and poorer functional status.
Time frame: 03 weeks
Functional Capacity
Evaluation will be done by using 6 minute walk test
Time frame: 03 weeks
Started Feb 2026 (actual). Primary completion is estimated for May 2026, 2 months after the start.
Of 1,099 non-industry interventional studies with no phase under Pulmonary Disease, Chronic Obstructive, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 41. This study's planned 2 months is below that.
Counting every sponsor, half of 1,187 studies reached it within 22 months; a quarter within 10 and three quarters within 39.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Pulmonary Disease, Chronic Obstructive →
Foundation University Islamabad →